Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model - sprookjes - yvandenbroek - TriplyDB

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

http://www.wikidata.org/entity/Q33527427

about

Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors Reciprocal relationship between myeloid-derived suppressor cells and T cells Th17 Cell Plasticity and Functions in Cancer Immunity Myeloid cells in the tumor microenvironment: Role of adenosine Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment Research progress in muscle-derived stem cells: Literature retrieval results based on international database Immunological and regenerative aspects of hepatic mast cells in liver allograft rejection and tolerance.Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges.Th17 cells in cancer: help or hindrance?IL-17A and IL-2-expanded regulatory T cells cooperate to inhibit Th1-mediated rejection of MHC II disparate skin grafts.Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance.Trial watch: Prognostic and predictive value of the immune infiltrate in cancer IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression Mast cells impair the development of protective anti-tumor immunity.Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses.Mast cell: insight into remodeling a tumor microenvironment.The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer.The Role of Mast Cells in Molding the Tumor Microenvironment.Emerging strategies for cancer immunoprevention.AllergoOncology - the impact of allergy in oncology: EAACI position paper.The role of myeloid cells in cancer therapies.Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors.T helper type 17 cells contribute to anti-tumour immunity and promote the recruitment of T helper type 1 cells to the tumour.Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity.Skin Immunity.Heterogeneity and Stability in Foxp3+ Regulatory T Cells.Distribution of mast cells in benign odontogenic tumors.Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value.Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment.

P2860

Q24306212-FEA61A60-C37F-4182-A38F-914A7EA688C0 Q27000664-3FC80814-F45B-4188-B84F-F68CA7794DDF Q27012901-EF27E778-47A1-425C-964B-3A303B8CB610 Q28069621-72B95B7B-9947-4F59-A4DD-E8E586F5DE48 Q28077126-2D74971A-6001-470A-B8DC-580D72BC6CBD Q28543751-E4F7BC4A-75F5-47CB-AFF1-1B5D5F93089F Q34277866-40B23333-364C-46DB-B357-D8DDA9AD86CC Q34570874-C7FF63F1-8EB9-41DF-91EB-6E3D062E3116 Q34624383-28EF95AB-5450-4B3D-AD75-17C911890334 Q34913808-4B499B1F-3104-48D2-B67C-11734A6B49E1 Q35022593-80DC2F15-BF68-4249-A467-3069512739CC Q35071167-5790F700-F2A2-4D31-8660-89408500B3F4 Q35402371-9B8ECA66-94CA-4943-88F7-77E66EB8C559 Q35597086-D6A4A612-CB7D-4EFB-B1BE-DD361DA563DE Q35613040-B7F0DF87-2466-4B74-8002-411F02801633 Q35634179-9E67CFAE-8030-4D73-9FEF-588736BEFEB1 Q35944713-3F4A6F1A-2A86-4EE9-8126-396181705A6E Q36456483-581020CD-91EE-4A39-AAD6-2BF83B98EECC Q36545043-8F27F2D7-B88E-4D68-AF69-CB43BA7705CA Q36917913-12AFB347-20C2-4F28-90E1-DF950A4A55DE Q37191046-28E14CB4-1F72-4ECC-B2C0-E5E4A75DCF6F Q37254993-C0F9C55C-D4ED-46E4-BC38-F0F60B35CEFB Q37644978-0EE7BA49-6E72-4595-A95E-D2A04FDA93B5 Q37644986-52FCC009-7910-469A-9E55-C13FE70021F5 Q37832440-4DE6F491-6D61-4C71-B829-773C7B1B5348 Q38010707-AFCE0B53-0BAD-4697-A6B7-E7D24AD4618F Q38181085-FDB4ADFB-24F5-491C-A4DB-7E8851302130 Q38246547-D80BDF84-FCAE-41D6-BE89-8B0FAF493C9F Q38585850-AA64A000-2AF2-4B71-B8B5-340B1618F526 Q38776716-D1AB402D-3361-4BF7-B37F-6367F22D168E Q38875474-74136917-A28F-4EEB-B00B-1B62A2C51134 Q38878888-B86779AA-68D7-40B5-92E1-45C8EFF8F857 Q39218352-1DB4C392-E2F7-454E-A121-050B6BD82CE6 Q39329954-B011CD34-4B6C-4B8A-9BF2-BE5E48AAC679 Q39379300-9C9F85FB-3628-4310-B668-09256B00078B Q39428491-1C400F9C-830A-4A9A-B6BC-A4C35B64C77C Q39436005-D7835B73-5A7C-40B3-9594-662BB11879B5 Q40087957-14F9CDC1-8439-4D09-B024-E60C2D055686 Q40695658-E8DA2E94-E1B5-45C8-A363-FB39C621425F Q41592522-D4E2E901-DB1F-49CD-AEA2-973945806F5F

P2860

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

http://www.wikidata.org/entity/Q33527427

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@ast

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@en

Mast cells mobilize myeloid-de ...... murine hepatocarcinoma model.

@nl

type

label

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@ast

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@en

Mast cells mobilize myeloid-de ...... murine hepatocarcinoma model.

@nl

prefLabel

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@ast

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@en

Mast cells mobilize myeloid-de ...... murine hepatocarcinoma model.

@nl

P1433

Q33527427-74BB1158-1797-4805-BB48-D602D59C22C4

P1476

Q33527427-C63AC4B4-72BD-4FBC-8531-78945F7A22E1

P2093

Q33527427-019635B5-4D37-496D-A0A9-D2E57F7B8009

Q33527427-152ECBB3-A2BA-4BF8-AD0D-35BB58135D2C

Q33527427-3F7BBBC5-3C29-47DC-9755-A44AB611187C

Q33527427-4E42C073-1621-49BE-9AAC-82FD479B68F1

Q33527427-7B37B76B-3B15-4ACC-A348-769967AB2317

Q33527427-7D7242FD-5B01-43EF-B848-F813C23FD252

P2860

Q33527427-01A55A3D-527D-4E6F-A18C-59CC82F38DF5

Q33527427-02CC2D2B-6946-446C-9C3A-C14B8B030E6B

Q33527427-04F50802-5FE6-4469-BF48-6FAE36270A67

Q33527427-05FB0557-0EE8-44D1-B95F-46CE242F0DF7

Q33527427-0806418A-BDF4-4CD1-B97C-B86126B582E7

Q33527427-118960A4-7567-4B86-A3A6-17403DDDB028

Q33527427-1E7FC495-15D0-48EF-B796-4D5310254BD4

Q33527427-228F5345-5EAC-41CD-9C64-83114E516A9C

Q33527427-29520A4D-7171-4516-8157-B1874736AE95

Q33527427-2FB6A883-0A5F-43A8-A6A2-19D8326B41EB

P304

Q33527427-6A572B3A-3702-497C-932E-27836A4737BD

P31

Q33527427-4CE17686-0A6D-42F0-8460-D0E016B58B65

P356

Q33527427-F49D00F7-E436-4ADD-9821-973C48ABD0CA

P407

Q33527427-B4633BBB-C90D-4275-9F54-3FFC4FDD8D6A

P433

Q33527427-3AF31B8B-E653-4EDB-B972-3A1B19A2564F

P478

Q33527427-C4AAB04F-451E-4DCD-A3AB-CD7B611B7259

P50

Q33527427-FEBAEB25-E7A2-4987-B729-B790AAAB28EA

P577

Q33527427-09DAAB5B-9095-4C79-91F8-9D57799EAE3E

P5875

Q33527427-73BF4FED-8018-4ED9-8F87-F9C35E9DD5C8

P698

Q33527427-886FCE0F-19D2-4D17-A201-2B41F8CC1C9D

P921

Q33527427-6335A1DB-08A6-420F-8F6C-9D6365A03B91

P932

Q33527427-9E44A3C4-A6AE-4CF7-839E-D11A38A607E7

P356

JOURNAL.PONE.0008922

P1433

P1476

Mast cells mobilize myeloid-de ...... n murine hepatocarcinoma model

@en

P2093

Biao Zhang

http://www.w3.org/2001/XMLSchema#string

Bo Huang

http://www.w3.org/2001/XMLSchema#string

Chunmei Huang

http://www.w3.org/2001/XMLSchema#string

Dapeng Li

http://www.w3.org/2001/XMLSchema#string

Guan-Xin Shen

http://www.w3.org/2001/XMLSchema#string

Zhuoshun Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells: linking inflammation and cancer

Tumor-specific Th17-polarized cells eradicate large established melanoma

Myeloid-derived suppressor cells as regulators of the immune system

Paradoxical roles of the immune system during cancer development

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Regulatory T cells and immune tolerance

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

CTLA-4 control over Foxp3+ regulatory T cell function

Immunosuppressive strategies that are mediated by tumor cells

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

P304

e8922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0008922

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41174995

http://www.w3.org/2001/XMLSchema#string

P698

20111717

http://www.w3.org/2001/XMLSchema#string

P921

P932

2811741

http://www.w3.org/2001/XMLSchema#string